Vor Biopharma Inc. (VOR) Misses Q1 EPS by 6c
Tweet
Share
E-mail
Get Alerts VOR Hot Sheet
Join SI Premium – FREE
Vor Biopharma Inc. (NASDAQ: VOR) reported Q1 EPS of ($0.45), $0.06 worse than the analyst estimate of ($0.39).
For earnings history and earnings-related data on Vor Biopharma Inc. (VOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lindsay (LNN) Tops Q3 EPS by 18c, Misses on Revenue
- APi Group closes WTech Fire Group deal, raises 2026 guidance
- Lucid reports Q2 output, names new CFO and five other leaders
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
